The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
Summary of "The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma."
Purpose:  To evaluate the long-term effects and costs of four treatment strategies for primary open-angle glaucoma compared to usual care. Methods:  Cost-effectiveness analyses with a lifelong horizon were made from a societal perspective. Data were generated with a patient-level model based on discrete event simulation. The model structure and parameter estimates were based on literature, particularly clinical studies on the natural course of glaucoma and the effect of treatment. We simulated heterogeneous cohorts of 3000 patients and explored the impact of uncertainty with sensitivity analyses. Results:  The incremental cost-effectiveness ratio (ICER) of initial treatment with a prostaglandin analogue compared with a β-blocker was €12.931 per quality-adjusted life year (QALY) gained. A low initial target pressure (15 mmHg) resulted in 0.115 QALYs gained and €1550 saved compared to a gradual decrease from 21 to 15 mmHg upon progression. Visual field (VF) measurements every 6 rather than 12 months lead to health gains at increased costs (ICER €173 486 per QALY gained), whereas measurements every 24 months lead to health losses at reduced costs (ICER €21 516 per QALY lost). All treatment strategies were dominant over 'withholding treatment'. Conclusions:  From a cost-effectiveness point of view, it seems advantageous to aim for a low intraocular pressure in all glaucoma patients. The feasibility of this strategy should therefore be investigated. Additionally, the cost-effectiveness outcomes of initiating monotherapy with a prostaglandin analogue and reducing the frequency of VF testing may be acceptable.
Affiliation
University Eye Clinic, Maastricht University Medical Center, Maastricht, The Netherlands Institute of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands Department of Health Organisation, Policy, and Econo
Journal Details
This article was published in the following journal.
Name: Acta ophthalmologica
ISSN: 1755-3768
Pages: 20-31
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22289192
- DOI: http://dx.doi.org/10.1111/j.1755-3768.2011.02318.x
Medical and Biotech [MESH] Definitions
Hiv Long-term Survivors
Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment.
Insurance, Long-term Care
Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.
Long-term Potentiation
A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory.
Long-term Synaptic Depression
A persistent activity-dependent decrease in synaptic efficacy between NEURONS. It typically occurs following repeated low-frequency afferent stimulation, but it can be induced by other methods. Long-term depression appears to play a role in MEMORY.
Penfluridol
One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.
PubMed Articles
BACKGROUND: Multi-component vocational rehabilitation (VR) provides positive short-term outcomes in patients with prolonged fatigue. PURPO...
CPAP is used as the first-line treatment for patients with severe OSA, but this machine is not always feasible to use on the long term. We performed a clinical trial to determine whether patients with...
Long-Term Treatment with Fumaric Acid Esters in an 11-Year-Old Male Child with Psoriasis.
Moderate to severe psoriasis is common in childhood and adolescence and is often a challenge for the treating dermatologist. In most cases, systemic therapies in children are only available 'off-label...
Evidence-based pharmacotherapy of obsessive-compulsive disorder.
Pharmacological strategies for the treatment of obsessive-compulsive disorder (OCD) continue to develop apace but deficiencies remain. We present an updated literature review of the evidence supportin...
Clinical Trials
Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
The development of a vaccine against HIV/AIDS has been primary focused on the structural proteins (Env, Gag) of HIV-1 with the aim of inducing sterilizing immunity by blocking virus entry....
Children and adolescents with HIV/AIDS are living well beyond life expectancy that was projected for them in the recent past. Little is known about the psychosocial variables that coincid...
Treatment of acute primary HIV infection may improve long-term outcome. However, optimal treatment is still debated. The ANRS 112-INTERPRIM trial evaluates three different therapeutical st...
Evaluating Strategies to Control Hypercholesterolemia
To determine the cost-effectiveness of alternative strategies for cholesterol reduction.
Behavioral Strategies for Weight Management
Although studies demonstrate that people who consistently keep detailed food records are more likely to maintain their weight, few people continue to keep records given the vigilant attent...
